Prescribing of Rosiglitazone and Pioglitazone Following Safety Signals-Reference-Cited by-同舟云学术

Prescribing of Rosiglitazone and Pioglitazone Following Safety Signals

Published:2012-06 Issue:6 Volume:35 Page:471-480
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Safety

Author:

Ruiter Rikje,Visser Loes E.,van Herk-Sukel Myrthe P.P.,Geelhoed-Duijvestijn Petronella H.,de Bie Sandra,Straus Sabine M.J.M.,Mol Peter G.M.,Romio Silvana A.,Herings Ron M.C.,Stricker Bruno H.Ch.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Reference22 articles.

1. Global Prevalence of Diabetes

2. Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: A prospective population-based study in The Netherlands (ZODIAC-1)

3. Revised guideline for prescribing vigabatrin in children

4. Vision Loss Due to Macular Edema Induced by Rosiglitazone Treatment of Diabetes Mellitus

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the Impact on Health of Pharmacovigilance Activities: Example of Four Safety Signals;Drug Safety;2021-02-19

2. Regulatory post‐market drug safety advisories on cardiac harm: A comparison of four national regulatory agencies;Pharmacology Research & Perspectives;2020-11-09

3. Do drug‐related safety warnings have the expected impact on drug therapy? A systematic review;Pharmacoepidemiology and Drug Safety;2020-02-11

5. Effects of sodium glucose cotransporter type 2 inhibitors on heart failure;Diabetes, Obesity and Metabolism;2019-04